Effects of Mammography Screening Under Different Screening Schedules: Model Estimates of Potential Benefits and Harms

被引:477
|
作者
Mandelblatt, Jeanne S. [1 ]
Cronin, Kathleen A.
Bailey, Stephanie
Berry, Donald A.
de Koning, Harry J.
Draisma, Gerrit
Huang, Hui
Lee, Sandra J.
Munsell, Mark
Plevritis, Sylvia K.
Ravdin, Peter
Schechter, Clyde B.
Sigal, Bronislava
Stoto, Michael A.
Stout, Natasha K.
van Ravesteyn, Nicolien T.
Venier, John
Zelen, Marvin
Feuer, Eric J.
机构
[1] Lombardi Comprehens Canc Ctr, Washington, DC 20007 USA
关键词
CARCINOMA IN-SITU; BREAST-CANCER MORTALITY; UPPER AGE LIMIT; COST-EFFECTIVENESS; FOLLOW-UP; WOMEN; OLDER; OVERDIAGNOSIS; OVERTREATMENT; PERFORMANCE;
D O I
10.7326/0003-4819-151-10-200911170-00010
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Background: Despite trials of mammography and widespread use, optimal screening policy is controversial. Objective: To evaluate U. S. breast cancer screening strategies. Design: 6 models using common data elements. Data Sources: National data on age-specific incidence, competing mortality, mammography characteristics, and treatment effects. Target Population: A contemporary population cohort. Time Horizon: Lifetime. Perspective: Societal. Interventions: 20 screening strategies with varying initiation and cessation ages applied annually or biennially. Outcome Measures: Number of mammograms, reduction in deaths from breast cancer or life-years gained (vs. no screening), false-positive results, unnecessary biopsies, and overdiagnosis. Results of Base-Case Analysis: The 6 models produced consistent rankings of screening strategies. Screening biennially maintained an average of 81% (range across strategies and models, 67% to 99%) of the benefit of annual screening with almost half the number of false-positive results. Screening biennially from ages 50 to 69 years achieved a median 16.5% (range, 15% to 23%) reduction in breast cancer deaths versus no screening. Initiating biennial screening at age 40 years (vs. 50 years) reduced mortality by an additional 3% (range, 1% to 6%), consumed more resources, and yielded more false-positive results. Biennial screening after age 69 years yielded some additional mortality reduction in all models, but overdiagnosis increased most substantially at older ages. Results of Sensitivity Analysis: Varying test sensitivity or treatment patterns did not change conclusions. Limitation: Results do not include morbidity from false-positive results, patient knowledge of earlier diagnosis, or unnecessary treatment. Conclusion: Biennial screening achieves most of the benefit of annual screening with less harm. Decisions about the best strategy depend on program and individual objectives and the weight placed on benefits, harms, and resource considerations.
引用
收藏
页码:738 / W247
页数:15
相关论文
共 50 条
  • [31] Benefits, harms, and costs of newborn genetic screening for hypertrophic cardiomyopathy: Estimates from the PreEMPT model
    Christensen, Kurt D.
    McMahon, Pamela M.
    Galbraith, Lauren N.
    Yeh, Jennifer M.
    Stout, Natasha K.
    Lu, Christine Y.
    Stein, Sarah
    Zhao, Maryann
    Hylind, Robyn J.
    Wu, Ann Chen
    GENETICS IN MEDICINE, 2023, 25 (04)
  • [32] The benefits and harms of screening for cancer with a focus on breast screening
    Brodersen, John
    Jorgensen, Karsten J.
    Gotzsche, Peter C.
    POLSKIE ARCHIWUM MEDYCYNY WEWNETRZNEJ-POLISH ARCHIVES OF INTERNAL MEDICINE, 2010, 120 (03): : 89 - 93
  • [33] Benefits, Harms, and Costs for Breast Cancer Screening After US Implementation of Digital Mammography
    Stout, Natasha K.
    Lee, Sandra J.
    Schechter, Clyde B.
    Kerlikowske, Karla
    Alagoz, Oguzhan
    Berry, Donald
    Buist, Diana S. M.
    Cevik, Mucahit
    Chisholm, Gary
    de Koning, Harry J.
    Huang, Hui
    Hubbard, Rebecca A.
    Miglioretti, Diana L.
    Munsell, Mark F.
    Trentham-Dietz, Amy
    van Ravesteyn, Nicolien T.
    Tosteson, Anna N. A.
    Mandelblatt, Jeanne S.
    JNCI-JOURNAL OF THE NATIONAL CANCER INSTITUTE, 2014, 106 (06):
  • [34] Estimating net benefits and harms of screening mammography in women age 40 to 49 years
    Djulbegovic, Benjamin
    Hozo, Iztok
    Lyman, Ga H.
    ANNALS OF INTERNAL MEDICINE, 2007, 147 (12) : 882 - 882
  • [35] Benefits and risks of mammography screening
    Junkermann, Hans
    ONKOLOGE, 2017, 23 (06): : 422 - 428
  • [36] Benefits, harms and costs of screening mammography in women 70 years and over: a systematic review
    Barratt, AL
    Irwig, LM
    Glasziou, PP
    Salkeld, GP
    Houssami, N
    MEDICAL JOURNAL OF AUSTRALIA, 2002, 176 (06) : 266 - 271
  • [37] BENEFITS AND RISKS OF SCREENING MAMMOGRAPHY
    SICKLES, EA
    WESTERN JOURNAL OF MEDICINE, 1977, 126 (01): : 70 - 71
  • [38] Risk and Benefits of Screening Mammography
    Lannin, Donald R.
    JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION, 2014, 312 (06): : 649 - 649
  • [39] Can AI Reduce the Harms of Screening Mammography?
    McDonald, Elizabeth S.
    Conant, Emily F.
    RADIOLOGY-ARTIFICIAL INTELLIGENCE, 2023, 5 (06)
  • [40] The benefits and harms of screening older women
    Evans, Andrew
    FUTURE ONCOLOGY, 2019, 15 (7S) : 11 - 12